C/EBPβ/AEP signaling couples atherosclerosis to the pathogenesis of Alzheimer's disease

Jianming Liao1,2, Guiqin Chen1,3, Xia Liu1

  • 1Department of Pathology and Laboratory Medicine, Emory University School of Medicine, Atlanta, GA, 30322, USA.

Molecular Psychiatry
|April 15, 2022
PubMed

Insights

The C/EBPβ/AEP pathway links atherosclerosis and Alzheimer's disease by mediating vascular pathology. This signaling pathway impacts cholesterol, foam cell formation, and cognitive function in mouse models.

Area of Science:

  • Neuroscience
  • Cardiovascular Biology
  • Immunology

Background:

  • Atherosclerosis (ATH) and Alzheimer's disease (AD) are age-related inflammatory conditions with shared molecular pathways.
  • The transcription factor C/EBPβ and asparagine endopeptidase (AEP) are implicated in both ATH and AD.
  • The precise role of C/EBPβ/AEP signaling in connecting ATH to AD pathogenesis is not fully understood.

Purpose of the Study:

  • To investigate whether C/EBPβ/AEP signaling mediates ATH pathology and links ATH to AD.
  • To elucidate the role of this pathway in vascular pathology and cognitive decline.

Main Methods:

  • Utilized ApoE-/- and 3xTg AD mouse models, including 3xTg/ApoE-/- double knockouts.
  • Manipulated C/EBPβ and AEP levels via gene deletion or knockdown.
  • Assessed macrophage cholesterol load, foam cell formation, aortic lesions, serum LDL levels, cerebral blood flow, and cognitive function.

Main Results:

  • Inactivation of C/EBPβ/AEP diminished cholesterol load, reduced foam cell formation, and decreased aortic lesions in high-fat-diet-fed ApoE-/- mice.
  • In 3xTg/ApoE-/- mice, C/EBPβ or AEP depletion attenuated ATH markers, improved cerebral blood flow and vessel length, and restored cognitive function.
  • ApoE knockdown in 3xTg mice worsened AD pathology and cognitive deficits, effects alleviated by C/EBPβ/AEP pathway inactivation.

Conclusions:

  • The C/EBPβ/AEP signaling pathway is a critical mediator connecting atherosclerosis to Alzheimer's disease.
  • This pathway influences vascular pathology, including cholesterol metabolism and lesion formation.
  • Targeting the C/EBPβ/AEP pathway holds potential for treating co-occurring ATH and AD.

Related Concept Videos

Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
696
Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
129
Alzheimer's Disease: Treatment01:22

Alzheimer's Disease: Treatment

Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
272
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.6K
Notch Signaling Pathway03:14

Notch Signaling Pathway

The Notch signaling pathway is a major intracellular signaling pathway that is highly conserved over a broad spectrum of metazoan species. It stands unique from other intracellular signaling mechanisms in animals because notch protein itself acts as the receptor as well as the primary signaling molecule.
The Notch gene came into the limelight in 1914 after the discovery that its mutation in Drosophila melanogaster leads to a serrated (or "notched") wing margin phenotype. It was not...
4.5K
cAMP-dependent Protein Kinase Pathways01:25

cAMP-dependent Protein Kinase Pathways

Cyclic Adenosine Monophosphate (cAMP) is an essential second messenger that activates protein kinase A (PKA) and regulates various biological processes. A single epinephrine molecule binds to GPCR and activates several heterotrimeric G proteins, each stimulating multiple adenylyl cyclase, amplifying the signal, and synthesizing large numbers of cAMP molecules. Small changes in cAMP concentration affect PKA activity. The binding of four cAMP molecules induces a conformational change in PKA,...
6.7K